2 results
Approved WMOCompleted
To test whether treatment with oral imatinib reduce disease burden and consumption of medical resources.
Approved WMORecruiting
The primary objective of this study is to prove noninferiority regarding safety and effectiveness of 30-45 day of DAPT followed by Prasugrel-monotherapy versus standard 12 months of DAPT in patients admitted for STEMI treated by primary PCI.The…